BR112014009323A2 - uso de micélios de proteína de soro de leite para melhorar o gasto de energia e a saciedade - Google Patents

uso de micélios de proteína de soro de leite para melhorar o gasto de energia e a saciedade

Info

Publication number
BR112014009323A2
BR112014009323A2 BR112014009323A BR112014009323A BR112014009323A2 BR 112014009323 A2 BR112014009323 A2 BR 112014009323A2 BR 112014009323 A BR112014009323 A BR 112014009323A BR 112014009323 A BR112014009323 A BR 112014009323A BR 112014009323 A2 BR112014009323 A2 BR 112014009323A2
Authority
BR
Brazil
Prior art keywords
mycelia
whey protein
satiety
energy expenditure
patient
Prior art date
Application number
BR112014009323A
Other languages
English (en)
Other versions
BR112014009323B1 (pt
Inventor
Breuille Denis
Pouteau Etienne
John Acheson Kevin
Jean René Bovetto Lionel
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47178585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014009323(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112014009323A2 publication Critical patent/BR112014009323A2/pt
Publication of BR112014009323B1 publication Critical patent/BR112014009323B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Feed For Specific Animals (AREA)

Abstract

resumo patente de invenção: "uso de micélios de proteína de soro de leite para melhorar o gasto de energia e a saciedade". a presente invenção refere-se a micélios de proteína de soro de leite para uso no tratamento e/ou a prevenção de sobrepeso e/ou obesidade em um paciente. a invenção se refere também a um uso não terapêutico de micélios de proteína de soro de leite para aumentar a saciedade e/ou o gasto de energia pós-prandial em um paciente. um aspecto adicional da presente invenção é uma composição alimentícia a ser administrada a um paciente com sobrepeso ou obeso, ou a um paciente em perigo de se tornar com sobrepeso ou obeso.
BR112014009323-7A 2011-10-21 2012-10-19 Usos de micelas de proteína de soro de leite BR112014009323B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11186146.4 2011-10-21
EP11186146.4A EP2583565A1 (en) 2011-10-21 2011-10-21 Use of whey protein micelles for enhancing energy expenditure and satiety
PCT/EP2012/070713 WO2013057229A1 (en) 2011-10-21 2012-10-19 Use of whey protein micelles for enhancing energy expenditure and satiety

Publications (2)

Publication Number Publication Date
BR112014009323A2 true BR112014009323A2 (pt) 2017-04-11
BR112014009323B1 BR112014009323B1 (pt) 2020-07-14

Family

ID=47178585

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014009323-7A BR112014009323B1 (pt) 2011-10-21 2012-10-19 Usos de micelas de proteína de soro de leite

Country Status (10)

Country Link
US (2) US20140271984A1 (pt)
EP (2) EP2583565A1 (pt)
JP (1) JP2014532617A (pt)
CN (1) CN103889249B (pt)
AU (1) AU2012324883B2 (pt)
BR (1) BR112014009323B1 (pt)
CA (1) CA2853165C (pt)
DK (1) DK2768324T3 (pt)
ES (1) ES2621482T3 (pt)
WO (1) WO2013057229A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2583564A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for improving insulin profile in diabetic patients
EP2583563A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Whey protein micelles against muscle atrophy and sarcopenia
US20170332667A1 (en) * 2014-11-04 2017-11-23 Mars, Incorporated Extruded pet food product
US20180325978A1 (en) * 2014-11-19 2018-11-15 Nestec S.A. Use of complexes of whey protein micelles and pectin for managing body weight
CN107846951A (zh) * 2015-06-05 2018-03-27 菲仕兰康必奶荷兰有限公司 自支持乳品组合物
JP6861708B2 (ja) * 2015-12-30 2021-04-21 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 除脂肪体重を測定するための方法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JP7266581B2 (ja) 2017-08-14 2023-04-28 アクセラ・ヘルス・インコーポレイテッド 肝疾患の治療のためのアミノ酸組成物
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683492B2 (ja) * 1993-09-07 1997-11-26 雪印乳業株式会社 ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法
US5595772A (en) * 1995-06-07 1997-01-21 Massachusetts Institute Of Technology Composition and methods for losing weight
DE19964370B4 (de) * 1999-02-16 2006-05-11 Huss, Manfred Herstellung eines geschäumten Molkenproteinprodukts
US20020150649A1 (en) * 2001-02-14 2002-10-17 Bell Stacey J. Nutritional supplement for pediatric obesity
US20030138547A1 (en) * 2002-01-22 2003-07-24 Mars, Incorporated Weight management system for animals
CN101035594B (zh) * 2004-08-09 2013-10-23 酶学技术有限公司 用于糖尿病患者的食品
MY153295A (en) * 2004-09-29 2015-01-29 Nestec Sa Nanoparticulated whey proteins
US8597709B2 (en) * 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
PL1839492T3 (pl) * 2006-03-27 2012-02-29 Nestec Sa Micele białka serwatkowego
EP2409575B1 (en) * 2008-10-17 2017-02-22 Nestec S.A. Method for making whey protein compositions
US20100278981A1 (en) * 2009-04-22 2010-11-04 Gary Ervin Meal Replacement and Appetite Control/ Diet System
CA2768471A1 (en) * 2009-07-20 2011-01-27 Nestec S.A. Methods of attenuating the loss of functional status
WO2011078654A1 (en) * 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
RU2012143622A (ru) * 2010-03-12 2014-04-20 Нестек С.А. Композиции для маскировки вкуса нутриентов и способы их изготовления

Also Published As

Publication number Publication date
BR112014009323B1 (pt) 2020-07-14
EP2768324B1 (en) 2017-02-01
ES2621482T3 (es) 2017-07-04
JP2014532617A (ja) 2014-12-08
CN103889249A (zh) 2014-06-25
AU2012324883A1 (en) 2014-05-01
US20140271984A1 (en) 2014-09-18
WO2013057229A1 (en) 2013-04-25
CN103889249B (zh) 2017-05-03
US20210401024A1 (en) 2021-12-30
EP2583565A1 (en) 2013-04-24
DK2768324T3 (en) 2017-02-27
CA2853165C (en) 2023-04-11
AU2012324883B2 (en) 2015-12-10
EP2768324A1 (en) 2014-08-27
CA2853165A1 (en) 2013-04-25

Similar Documents

Publication Publication Date Title
BR112014009323A2 (pt) uso de micélios de proteína de soro de leite para melhorar o gasto de energia e a saciedade
EA201190325A1 (ru) Специфичные к меланокортиновым рецепторам пептиды
UY32497A (es) "2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso"
ATE476418T1 (de) Benzamidderivate und assoziierte verwendungen
TN2015000283A1 (fr) Functionalized exendin-4 derivatives
IN2014KN02830A (pt)
BR112012018386A8 (pt) "inibidores isoindolinona de fosfatidilinositol 3-quinase"
NZ606768A (en) Pharmaceutical compositions and methods of treatment
BRPI0809047B8 (pt) composição, aditivo alimentar e métodos para tratar ou prevenir diabetes ou obesidade e para reduzir o índice glicêmico de um alimento contendo carboidrato
BR112015024757A2 (pt) métodos para aprimorar síntese de proteína muscular seguindo treinamento simultâneo
AR058098A1 (es) Derivados de acidos dicarboxilicos y su uso
UY31765A (es) Dihidropirazolonas sustituidas y su uso
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
MX351664B (es) Producto dietetico destinado a la disminucion de la grasa visceral en parte preoperatoria bariatrica.
BR112016021985A8 (pt) formulação farmacêutica e composto
BR112014009225A8 (pt) uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes
MX2013011833A (es) Formula infantil para ser usada en la prevencion de enfermedades cardiovasculares.
RU2018138995A (ru) Способы индуцирования и пролонгирования насыщения, уменьшения объёма и поглощения пищи, контроля веса и стимулирования снижения веса, пищевая композиция
AU2018256619A1 (en) Compounds for the treatment of obesity and methods of use thereof
WO2015095354A3 (en) Compositions and methods for treating fatty tissue buildup
EA201300592A1 (ru) Ингибиторы апоптоза и их применение
BR112013013112A2 (pt) uso de uma composição tendo uma densidade de energia entre 0,9 e 1,5 kcal/ml, composição para uso no controle de níveis de colesterol e triglicérides em um paciente que apresenta diabetes tipo 2
DOP2010000156A (es) Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca
EA201590522A1 (ru) Способы введения рифаксимина для снижения веса и лечения ожирения
BR112015010639A2 (pt) lactobacillus rhamnosus para redução da acumulação de gordura corporal

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 35/20 (2006.01), A61P 3/04 (2006.01)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/10/2012, OBSERVADAS AS CONDICOES LEGAIS.